11-Aug-2026 - MSN 5 must-read analyst questions from Insulet’s Q2 earnings call Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While ...
6-Aug-2026 - The Globe and Mail Insulet’s (NASDAQ:PODD) Q2 CY2026 Sales Top Estimates But Stock Drops In Q2, Insulet reported adjusted EPS of $1.66, up from $1.17 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the ...
5-Aug-2026 - The Globe and Mail Why Insulet (PODD) Shares Are Sliding Today Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 20.5% in the afternoon session after the company ...
5-Aug-2026 - StockStory.org Why Insulet (PODD) shares are sliding today What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 20.5% in the afternoon session after ...
11-Aug-2026 - MSN 5 must-read analyst questions from Insulet’s Q2 earnings call Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While ...
6-Aug-2026 - The Globe and Mail Insulet’s (NASDAQ:PODD) Q2 CY2026 Sales Top Estimates But Stock Drops In Q2, Insulet reported adjusted EPS of $1.66, up from $1.17 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the ...
5-Aug-2026 - The Globe and Mail Why Insulet (PODD) Shares Are Sliding Today Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 20.5% in the afternoon session after the company ...
5-Aug-2026 - StockStory.org Why Insulet (PODD) shares are sliding today What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 20.5% in the afternoon session after ...
